Oil, Gas and Consumable Fuels
Company Overview of Solazyme, Inc.
Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blendstocks for marine, motor vehicle, and jet fuels, as well as replacements for petrochemicals, oleochemicals, and functional fluids. It also provides fuels, including SoladieselBD and SoladieselRD for on-road applications; ultra-low sulfur diesel; and Solajet for aviation use. In addition, the company offe...
225 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2003
Key Executives for Solazyme, Inc.
Co-Founder, Chief Executive Officer and Director
Total Annual Compensation: $560.0K
Chief Financial Officer and Chief Operating Officer
Total Annual Compensation: $410.4K
Senior Vice President, General Counsel and Corporate Secretary
Total Annual Compensation: $335.0K
Chief Technology Officer
Total Annual Compensation: $370.8K
Total Annual Compensation: $378.8K
Compensation as of Fiscal Year 2014.
Solazyme, Inc. Key Developments
Labaton Sucharow LLP Files Class Action Lawsuit Against Solazyme, Inc
Jun 24 15
Labaton Sucharow LLP filed a securities class action lawsuit in the U.S. District Court for the Northern District of California. The lawsuit was filed on behalf of all persons or entities who, between February 27, 2014 and November 5, 2014, inclusive, purchased or otherwise acquired the publicly traded securities of Solazyme, Inc., including certain securities issued by Solazyme pursuant and/or traceable to either of two registered public offerings on or about March 27, 2014. The complaint charges Solazyme and certain of its officers and directors with violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder. The complaint alleges that certain Defendants made false and misleading statements and concealed material information relating to the construction progress, development, and expected production capacity of the company’s renewable oils production facility located in Moema, Brazil. Specifically, Defendants caused Solazyme securities to trade at artificially inflated prices by improperly concealing ongoing construction delays due to insufficient access to electricity and steam utility services. These challenges prohibited the Moema Facility from scaling its capacity production as projected. Additionally, the complaint alleges that Solazyme, certain of its officers and directors, and the underwriters of the Offerings violated Sections 11, 12(a)(2), and 15 of the Securities Act of 1933. The complaint alleges that certain Defendants made false and misleading statements and failed to disclose material adverse information in offering documents filed with the U.S. Securities and Exchange Commission in connection with the issuance of (i) approximately $149.5 million in convertible notes on or about March 27, 2014, and (ii) 5.75 million shares of common stock on the same day at $11.00 per share for aggregate gross proceeds of approximately $63.25 million.
Natura Cosméticos S.A. and Solazyme, Inc. Announce Sales Agreement for Microalgae Oil
Jun 9 15
Natura Cosméticos S.A. and Solazyme, Inc. announced that after successfully completing testing and product validation phases over the past year using Solazyme's oils, Natura is purchasing Solazyme's high-performance AlgaP Microalgae Oil, which will be incorporated into Natura's multiple product lines. Solazyme's microalgae oils are produced in a matter of days using a fermentation process designed to produce oils of the utmost purity, performance and sustainability. Some of the benefits of using AlgaP oils for skin care are higher hydration levels, a silky but not greasy skin feel, mildness on the skin, neutral color and odor, and improved shelf life.
Solazyme, Inc. Presents at Cowen and Company 43rd Annual Technology, Media & Telecom Conference 2015, May-28-2015
May 26 15
Solazyme, Inc. Presents at Cowen and Company 43rd Annual Technology, Media & Telecom Conference 2015, May-28-2015 . Venue: The New York Palace Hotel, 455 Madison Avenue, New York, NY 10022, United States. Speakers: Tyler W. Painter, Chief Financial Officer and Chief Operating Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|